β-Amyloid (1-42)-induced learning and memory deficits in mice: Involvement of oxidative burdens in the hippocampus and cerebral cortex

Behavioural Brain Research

Volumn 155, Issue 2, 2004, Pages 185-196

  Jhoo, Jin Hyeong ^a,f   Kim, Hyoung Chun ^b   Nabeshima, Toshitaka ^c   Yamada, Kiyofumi ^d   Shin, Eun Joo ^b   Jhoo, Wang Kee ^b   Kim, Wookyung ^b   Kang, Kee Seok ^e   Jo, Sangmee Ahn ^e   Woo, Jong Inn ^f,g  

^a Bundang Jesaeng Hospital   (South Korea)

^b Kangwon National University   (South Korea)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

^e Korea National Institute of Health   (South Korea)

^f Seoul National University   (South Korea)

^g Seoul National University Hospital   (South Korea)

Author keywords

Alzheimer's disease; Amyloid beta protein; Glutathione peroxidase; Hippocampus; Memory impairments; Oxidative stress; Superoxide dismutase

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN[1-42]; CARBONYL DERIVATIVE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; HIPPOCAMPUS; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; PRIORITY JOURNAL; REACTION TIME; STATISTICAL SIGNIFICANCE;

ALPHA-TOCOPHEROL; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; AVOIDANCE LEARNING; CEREBRAL CORTEX; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; LIPID PEROXIDATION; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 4444304016     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2004.04.012     Document Type: Article

References (55)

1. Aksenov M.Y., Tucker H.M., Nair P., Aksenova M.V., Butterfield D.A., Estus S., et al. The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease. J. Mol. Neurosci. 11:1998;151-164
2. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 77:1994;817-827
3. Bush A.I., Pettingell W.H., Multhaup G., Paradis M.D., Vonsattel J.P., Gusella J.F., et al. Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science. 265:1994;1464-1467
4. Butterfield D.A., Hensley K., Harris M., Mattson M., Carney J. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:1994;710-715
5. Butterfield D.A., Stadtman E.R. Protein oxidation process in aging brain. Adv. Cell Aging Gerontol. 2:1997;161-191
6. Butterfield D.A., Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 32:2002;1050-1060
7. Cassarino D.S., Bennett J.P. Jr. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res. Rev. 29:1999;1-25
8. Ceballos I., Nicole A., Briand P., Grimber G., Dalacourte A., Falment S., et al. Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Downs syndrome. Free Radical Res. 12/13:1991;581-589
9. Cheng Z.J., Kuo S.C., Chan S.C., Ko F.N., Teng C.M. Antioxidant properties of butein isolated from Dalbergia odorifera. Biochim. Biophys. Acta. 1392:1998;291-299
10. Cherny R.A., Atwood C.S., Xilinas M.E., Gray D.N., Jones W.D., McLean C.A., et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 30:2001;641-642
11. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695
12. Daniels W.M., van Rensburg S.J., van Zyl J.M., Taljaard J.J. Meltonin prevents beta-amyloid-induced lipid peroxidation. J. Pineal. Res. 24:1998;78-82
13. Eklow L., Moldeus P., Orrenius S. Oxidation of glutathione during hydroperoxide metabolism. A study using isolated hepatocytes and the glutathione reductase inhibitor 1,3-bis(2-chloroethyl)-1-nitrosourea. Eur. J. Biochem. 138:1984;459-463
14. Floyd R.A., Carney J.M. Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann. Neurol. 32:1992;S22-S227
15. Frey W.H., Najarian M.M., Kurma K.S., Emory C.R., Menning P.M., Frank J.C., et al. Endogenous Alzheimer's brain factor and oxidized glutathione inhibit antagonist binding to muscarinic receptor. Brain Res. 724:1996;87-94
16. Hendrie H.C. Epidemiology of Alzheimer's disease. Geriatrics. 52:1997;S4-S8
17. Huang X., Atwood C.S., Hartshorn M.A., Multhaup G., Goldstein L.E., Scarpa R.C., et al. The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 38:1999;7609-7616
18. Itoh A., Nitta A., Nodai M., Nishimura K., Hirose M., Hasegawa T., et al. Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats. J. Neurochem. 66:1996;1113-1117
19. Itoh A., Akaike T., Sokabe M., Nitta A., Iida R., Olariu A., et al. Impairment of long-term potentiation in hippocampal slices of β-amyloid-infused rats. Eur. J. Pharmacol. 382:1999;167-175
20. Jareno E.J., Bosch-Morell F., Fernandez-Delgado R., Donat J., Romero F.J. Serum malondialdehyde in HIV seropositive children. Free Radic. Biol. Med. 24:1998;503-506
21. Jhoo W.K., Kim H.C., Yamada K., Im D.H., Shin E.J., Park S.J., et al. Prolonged exposure to β-amyloid protein enhances 4-hydroxy-2-nonenal modifies proteins in the rat brain. Soc. Neurosci. Abstr. 26:2000;1020
22. Kim H.C., Jhoo W.K., Choi D.Y., Im D.H., Shin E.J., Suh J.H., et al. Protection of methamphetamine nigrostriatal toxicity by dietary selenium. Brain Res. 851:1999;76-86
23. Kim H.C., Jhoo W.K., Bing G., Shin E.J., Wie M.B., Kim W.K., et al. Phenidone prevents kainate-induced neurotoxicity via antioxidant mechanisms. Brain Res. 874:2000;15-23
24. Kim H.C., Bing G., Jhoo W.K., Ko K.H., Kim W.K., Suh J.H., et al. Changes of hippocampal Cu/Zn-superoxide dismutase after kainate treatment in the rat. Brain Res. 853:2000;215-226
25. Kim H.C., Yamada K., Nitta A., Olariu A., Tran M.H., Mizuno M., et al. Immunocytochemical evidence that amyloid β (1-42) impairs endogenous antioxidant systems in vivo. Neuroscience. 119:2003;399-419
26. Laursen S.E., Belknap J.K. Intracerebroventricular injections in mice. Some methodological refinements. J. Pharmacol. Meth. 16:1986;355-357
27. Lawrence R.A., Burk R.F. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem. Biophys. Res. Commun. 71:1976;952-958
28. Liu R., Liu I.Y., Thompson R.F., Doctrow S.R., Malfroy B., Baudry M. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalse mimics. Proc. Natl. Acad. Sci. U.S.A. 100:2003;8526-8531
29. Lobo A., Launer L.J., Fratiglioni L., Andersen K., Di Carlo A., Breteler M.M., et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurol. Dis. Elderly Res. Group Neurol. 54:2000;S4-S9
30. Lynch T., Cherny R.A., Bush A.I. Oxidative processes in Alzheimer's disease: the role of Aβ-metal interactions. Exp. Gerontol. 35:2000;445-451
31. Lyras L., Cairns N.J., Jenner A., Jenner P., Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68:1997;2061-2069
32. McCord J.M., Fridovich I. Superoxide dismutase. Enzymatic function for erythrocuprein. J. Biol. Chem. 244:1969;6049-6055
33. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of iron homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68:1997;255-264
34. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147
35. Matsuoka Y., Picciano M., La Francois J., Duff K. Fibrillar β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease. Neuroscience. 104:2001;609-613
36. Maurice T., Lockhart B.P., Privat A. Amnesia induced by centrally administered β-amyloid peptides involves cholinergic dysfunction. Brain Res. 706:1996;181-193
37. Morris R. Developments of a water maze procedure for studying spatial learning in the rat. J. Neurosci. Meth. 11:1984;47-60
38. Niki E., Yamamoto Y., Komuro E., Sato K. Membrane damage due to lipid peroxidation. Am. J. Clin. Nutr. 53:1991;201S-205S
39. Nitta A., Itoh A., Hasegawa T., Nabeshima T. β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 170:1994;63-66
40. Nitta A., Fukuta T., Hasegawa T., Nabeshima T. Continous infusion of β-amyloid protein into cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn. J. Pharmacol. 73:1997;51-57
41. Oliver C.N., Ahn B.W., Moerman E.J., Goldstein S., Statman E.R. Age-related changes in oxidized proteins. J. Biol. Chem. 262:1987;5488-5491
42. Ratan R.R., Murphy T.H., Baraban J.M. Macromolecular systhesis inhibitors prevent oxidative stress-induced apoptosis by shunting cystein to glutathione. J. Neurosci. 14:1994;4385-4392
43. Reed D.J. Glutathione:toxicological implications. Ann Rev. Pharmcol. Toxicol. 30:1990;603-631
44. Stadtman E.R. Protein oxidation and aging. Science. 257:1992;1220-1224
45. Subramaniam R., Roediger F., Jorda B., Mattson M.P., Keller J.N., Waeg G., et al. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins. J. Nuerochem. 69:1997;1161-1169
46. Tran M.H., Yamada K., Olariu A., Mizuno M., Ren X.H., Nabeshima T. Amyloid β-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB J. 15:2001;1407-1409
47. Tran M.H., Yamada K., Nakajima A., Mizuno M., He J., Kamei H., et al. Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid β-peptide-induced cholinergic dysfunction. Mol. Psychiatry. 8:2003;407-412
48. Woo J.I., Lee J.H., Yoo K.Y., Kim C.Y., Kim Y.I., Shin Y.S. Prevalence estimation of dementia in a rural area of Korea. J. Am. Geriatr. Soc. 46:1998;983-987
49. Wortwein G., Stackman R.W., Walsh T.J., Vitamin E. prevents the place learning deficit and the cholinergic hypofunction induced by AF64A. Exp. Neurol. 125:1994;15-21
50. Yamada K., Tanaka T., Zou L.B., Senzaki K., Yano K., Osada T., et al. Long-term deprivation of oestrogens by ovariectomy potentiates β-amyloid-induced working memory deficits in rats. Br. J. Pharmacol. 128:1999;419-427
51. Yamada K., Tanaka T., Han D., Senzaki K., Kameyama T., Nabeshima T. Protective effects of idebenone and alpha-tocopherol on β-amyloid-(1-42)- induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. Eur. J. Neurosci. 11:1999;83-90
52. Yan J.J., Cho J.Y., Kim H.S., Kim K.L., Jung J.S., Huh S.O., et al. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br. J. Pharmacol. 133:2001;89-96
53. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 250:1996;279-282
54. Yatin S.M., Varadarajan S., Link C.D., Butterfield D.A. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42). Neurobiol. Aging. 20:1999;325-330
55. Yatin S.M., Varadarajan S., Butterfield D.A. Vitamin E prevents Alzheimer's amyloid beta-peptide (1-42)-induced neuronal protein oxidation and reactive oxygen species production. J. Alzheimers Dis. 2:2000;123-131